234 related articles for article (PubMed ID: 3410498)
1. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
Kroegel C; Yukawa T; Dent G; Chanez P; Chung KF; Barnes PJ
Immunology; 1988 Jul; 64(3):559-61. PubMed ID: 3410498
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of degranulation from human eosinophils by platelet-activating factor.
Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
[TBL] [Abstract][Full Text] [Related]
3. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
[TBL] [Abstract][Full Text] [Related]
4. Modulatory role of protein kinase C on the signal transduction pathway utilized by platelet-activating factor in eosinophil activation.
Kroegel C; Giembycz MA; Matthys H; Westwick J; Barnes PJ
Am J Respir Cell Mol Biol; 1994 Nov; 11(5):593-9. PubMed ID: 7946388
[TBL] [Abstract][Full Text] [Related]
5. Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation.
Tsunoda H; Sakuma Y; Shirato M; Obaishi H; Harada K; Yamada K; Shimomura N; Machida Y; Yamatsu I; Katayama K
Arzneimittelforschung; 1991 Mar; 41(3):224-7. PubMed ID: 1867658
[TBL] [Abstract][Full Text] [Related]
6. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
Giembycz MA; Kroegel C; Barnes PJ
J Immunol; 1990 May; 144(9):3489-97. PubMed ID: 2158510
[TBL] [Abstract][Full Text] [Related]
7. Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.
Yukawa T; Kroegel C; Evans P; Fukuda T; Chung KF; Barnes PJ
Immunology; 1989 Sep; 68(1):140-3. PubMed ID: 2807369
[TBL] [Abstract][Full Text] [Related]
8. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
9. Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils.
Kroegel C; Yukawa T; Westwick J; Barnes PJ
Biochem Biophys Res Commun; 1989 Jul; 162(1):511-21. PubMed ID: 2546554
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.
Kroegel C; Matthys H
Immunology; 1993 Feb; 78(2):279-85. PubMed ID: 8473016
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
[TBL] [Abstract][Full Text] [Related]
12. [Degranulation of human eosinophilic granulocytes by the platelet activating factor].
Kroegel C; Venge P; Matthys H; Barnes PJ
Pneumologie; 1990 Feb; 44 Suppl 1():234-5. PubMed ID: 2367375
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils.
Bankers-Fulbright JL; Kephart GM; Bartemes KR; Kita H; O'Grady SM
J Cell Sci; 2004 Nov; 117(Pt 24):5749-57. PubMed ID: 15507482
[TBL] [Abstract][Full Text] [Related]
16. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs.
Kato M; Imoto K; Miyake H; Oda T; Miyaji S; Nakamura M
J Pharmacol Sci; 2004 Aug; 95(4):435-42. PubMed ID: 15286429
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 activates human peripheral blood eosinophils.
Hoenstein R; Admon D; Solomon A; Norris A; Moqbel R; Levi-Schaffer F
Cell Immunol; 2001 Jun; 210(2):116-24. PubMed ID: 11520078
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
Tamura N; Agrawal DK; Townley RG
J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
[TBL] [Abstract][Full Text] [Related]
20. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.
Horie S; Kita H
J Immunol; 1994 Jun; 152(11):5457-67. PubMed ID: 7514638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
